Depletion of Omega-3 Fatty Acids in RBCs and Changes of Inflammation Markers in Patients With Morbid Obesity Undergoing Gastric Bypass.
Tahar HajriDouglas EwingToghrul TalishinskiyErica AmiandaSebastian EidHans SchmidtPublished in: The Journal of nutrition (2022)
This study presents evidence that RBC and PBMC n-3 FAs are severely reduced in patients with obesity after RYGB. DHA supplementation in PBMC moderates the production of inflammation markers, suggesting that n-3 FA supplementation would merit a trial in bariatric patients.
Keyphrases
- weight loss
- gastric bypass
- roux en y gastric bypass
- bariatric surgery
- fatty acid
- obese patients
- insulin resistance
- oxidative stress
- metabolic syndrome
- end stage renal disease
- type diabetes
- weight gain
- newly diagnosed
- clinical trial
- chronic kidney disease
- high fat diet induced
- prognostic factors
- randomized controlled trial
- study protocol
- peritoneal dialysis
- adipose tissue
- phase iii
- phase ii
- red blood cell